Sector coverage, delivered

Custom Healthcare & Life Sciences briefs, tailored to your coverage area.

In your inbox, on your schedule.

Track clinical milestones, regulatory approvals, and pharma consolidation as they happen. SectorBrief monitors Healthcare Dive, BioPharma Dive, and MedTech Dive, delivering sector updates, M&A deals, and your watchlist's stock performance daily.

First month free · Pricing from $5/month · Cancel anytime

What's in every brief

Executive Summary

Current coverage of your sector, opened with the most consequential item. Ranked by what matters to you.

Industry News

Capacity moves, pricing, regulation, leadership changes, guidance. Every item states what happened and the market consequence, with the source linked.

M&A, Venture Capital & Partnerships

Deals get their own section, never buried in the news. SEC 8-K deal filings are routed here directly, alongside announced, rumored, and completed transactions.

Stock Performance

Your watchlist's trading metrics: last twelve months, last month, last day, and the next earnings date for every name you track.

Tuned to your coverage

You set the fields below, and every brief is written with them in mind, covering your niche in a way no industry mailer can. SectorBrief's multi-model system utilizes a scoring algorithm to assess every story, deal, and filing for industry significance and alignment with your specific focus area to ensure only important, relevant content ends up in your inbox.

1You set your coverage
SectorTechnology · Healthcare · Energy · Financial Services · or any you cover
Sector FocusTailor your brief to your specific focus within your sector
GeographyWeight a region, or restrict coverage to it entirely
WatchlistUS and international tickers, plus private companies
CadenceWeekly or biweekly, any time, any day.
2We source your sector's news

Marquee trade press, wire services, and SEC filings for your sector, backfilled by targeted news search so nothing slips through.

3Every story gets a Score

Our rating algorithm grades each story, deal, and filing on industry significance and alignment with your specific focus and inputs.

4The best make the brief

The top-scored stories and deals within the lookback period are selected, down to your preferred number of each.

5Each story gets depth

We pull the full article and surrounding context behind every selected story to write a description that underscores why it matters.

6Your watchlist, quoted

Daily market data for every name you track: trailing performance and the next earnings date.

7Delivered on your cadence

The finished brief lands in your inbox on the day and hour you chose.

Covering Healthcare & Life Sciences

Healthcare and life sciences professionals track FDA decisions, clinical trial outcomes, reimbursement pressures, and acquisition activity that shape therapeutic pipelines and market access. SectorBrief monitors the publications where breaking news appears first, including Healthcare Dive, BioPharma Dive, MedTech Dive, and STAT News, plus targeted news search and wire services. Each brief covers new approvals and clinical results, regulatory guidance shifts, reimbursement policy changes, and company partnerships. The M&A section separately presents acquisition announcements, licensing deals, and venture funding, so you see deal flow without overlap with general news. For companies you're tracking, the watchlist table shows current valuations, stock momentum, and next earnings or clinical update dates. Tailor your coverage by therapeutic area, company type (pharma, biotech, medtech, diagnostics), and focus region. Receive your brief weekly or biweekly at your preferred time.

Among the sources we monitor for Healthcare & Life Sciences are Healthcare Dive, BioPharma Dive, MedTech Dive, STAT News, Pharmaceutical Technology, GEN - Genetic Engineering and Biotechnology News. Coverage also draws on wire services, SEC filings for US-listed names, and targeted news search.

Pricing

Core

$5/ month

One coverage area, tailored for your needs and delivered on your schedule.

First month free, cancel or upgrade anytime.

Build Your Brief

Enterprise

Let's talk

Coverage solutions tailored to your team's needs.

Multi-seat access, up to 5 coverage areas per seat, and supported onboarding.

Contact Us

Questions

Does SectorBrief track clinical trials and regulatory approvals for drugs in development?

Yes. We monitor FDA announcements, clinical trial registries, regulatory guidances, and news coverage of drug development timelines. SectorBrief also tracks press releases from companies in your watchlist. We don't have direct access to trial databases, but major trial results and approvals are covered in Healthcare Dive, STAT News, and related publications.

Can I track private biotech companies and their funding rounds?

Yes. You can add private biotech companies to your watchlist by name, and we'll monitor news for their funding announcements, partnerships, and clinical milestones. Every brief includes a dedicated venture and M&A section covering funding rounds, acquisitions, and licensing deals. Coverage comes from VentureBeat-style sources and targeted news search.

How does SectorBrief track reimbursement and pricing pressure in healthcare?

SectorBrief monitors reimbursement policy announcements, pricing debates, and regulatory guidance from CMS and other payers published in Healthcare Dive and related trade press. We also track SEC filings from public companies for pricing and reimbursement disclosures. For private companies, major reimbursement developments typically appear in trade coverage.

What does it cost to try SectorBrief?

The first month of Core is free; after that it's $5 a month for one coverage area. Pro is $10 a month for up to three coverage areas, billed from day one. Annual billing is available at $50 and $100 a year.

Related coverage

Technology & Software briefs · Financial Services & Fintech briefs · Paper & Packaging briefs · Energy & Utilities briefs · Water & Wastewater briefs · All sectors

Full sector coverage, delivered on your schedule.

Build Your Brief